1. Home
  2. ITW vs EXEL Comparison

ITW vs EXEL Comparison

Compare ITW & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Illinois Tool Works Inc.

ITW

Illinois Tool Works Inc.

HOLD

Current Price

$257.76

Market Cap

72.2B

Sector

Industrials

ML Signal

HOLD

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$40.87

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITW
EXEL
Founded
1912
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.2B
11.1B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ITW
EXEL
Price
$257.76
$40.87
Analyst Decision
Hold
Buy
Analyst Count
11
24
Target Price
$261.64
$45.18
AVG Volume (30 Days)
1.1M
2.6M
Earning Date
10-24-2025
11-04-2025
Dividend Yield
2.50%
N/A
EPS Growth
N/A
53.55
EPS
10.31
2.38
Revenue
$15,883,000,000.00
$2,288,218,000.00
Revenue This Year
$1.81
$9.84
Revenue Next Year
$3.40
$11.92
P/E Ratio
$25.04
$17.20
Revenue Growth
N/A
9.93
52 Week Low
$214.66
$31.90
52 Week High
$278.13
$49.62

Technical Indicators

Market Signals
Indicator
ITW
EXEL
Relative Strength Index (RSI) 66.19 43.05
Support Level $246.37 $43.00
Resistance Level $251.61 $44.79
Average True Range (ATR) 3.94 1.15
MACD 1.35 -0.45
Stochastic Oscillator 93.38 3.65

Price Performance

Historical Comparison
ITW
EXEL

About ITW Illinois Tool Works Inc.

Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one-fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test and measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers and fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: